A High-Affinity Peptide Ligand Targeting Syntenin Inhibits Glioblastoma

Autor: Jan Daberger, Louise S. Clemmensen, Kristian Strømgaard, Eduardo Felipe Alves Fernandes, Flor Abalde-Gil, Weontae Lee, Pascale Zimmermann, Raphael Leblanc, Petra Hamerlik, Renaud Vincentelli, Jeanette Hammer Andersen, Zeyu Jin, Vita Sereikaite, Bianca Wind, Marte Albrigtsen, Thomas M. T. Jensen, Maria Vistrup-Parry, Antonio L. Egea-Jimenez, Diana Aguilar-Morante, Linda M. Haugaard-Kedström, Kamilla E. Jensen, Ylva Ivarsson

Publikováno v: Haugaard-Kedstrom, L M, Clemmensen, L S, Sereikaite, V, Jin, Z, Fernandes, E F A, Wind, B, Abalde-Gil, F, Daberger, J, Vistrup-Parry, M, Aguilar-Morante, D, Leblanc, R, Egea-Jimenez, A L, Albrigtsen, M, Jensen, K E, Jensen, T M T, Ivarsson, Y, Vincentelli, R, Hamerlik, P, Andersen, J H, Zimmermann, P, Lee, W & Stromgaard, K 2021, ' A High-Affinity Peptide Ligand Targeting Syntenin Inhibits Glioblastoma ', Journal of Medicinal Chemistry, vol. 64, no. 3, pp. 1423-1434 . https://doi.org/10.1021/acs.jmedchem.0c00382
Journal of Medicinal Chemistry
Journal of Medicinal Chemistry, American Chemical Society, 2021, 64 (3), pp.1423-1434. ⟨10.1021/acs.jmedchem.0c00382⟩
Journal of Medicinal Chemistry, 2021, 64 (3), pp.1423-1434. ⟨10.1021/acs.jmedchem.0c00382⟩

This document is the Accepted Manuscript version of a Published Work that appeared in final form in the Journal of Medicinal Chemistry, copyright © 2021 American Chemical Society, after peer review and technical editing by the publisher. To access t

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8215a973d5782c2b47dd3c1eb5542d4f
https://curis.ku.dk/ws/files/313014309/syntenin_manuscript_JMC_revised_120820_VS_1_1_.pdf